UNITED STATES – Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and most expensive level of clinical testing. The ...

When Dr. Purzner arrived in Kingston in 2021 and started to lead a revamping of the brain-tumour program, she wanted to marry her entrepreneurial experience with her clinical background.